SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-145668
Filing Date
2023-05-16
Accepted
2023-05-16 08:15:30
Documents
16
Period of Report
2023-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d466754d8k.htm   iXBRL 8-K 34185
2 EX-2.1 d466754dex21.htm EX-2.1 400007
3 EX-99.1 d466754dex991.htm EX-99.1 10137
7 GRAPHIC g466754g0516052142917.jpg GRAPHIC 3510
8 GRAPHIC g466754img.jpg GRAPHIC 3091
  Complete submission text file 0001193125-23-145668.txt   681608

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bvs-20230510.xsd EX-101.SCH 2853
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20230510_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20230510_pre.xml EX-101.PRE 11710
10 EXTRACTED XBRL INSTANCE DOCUMENT d466754d8k_htm.xml XML 3471
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 23925642
SIC: 3841 Surgical & Medical Instruments & Apparatus